Domestic Guidance on Celecoxib, Naproxen Released

Published: 2004-12-27 06:56:00

Updated: 2004-12-27 06:56:00

The Korea Food and Drug Administration (KFDA) released its pharmaceutical safety memorandum addressed to the healthcare professionals and to the general public, citing its current effort in reviewing the safety issues for drugs containing the active ingredients of celecoxib and naproxen, and the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK